JP2011504487A5 - - Google Patents

Download PDF

Info

Publication number
JP2011504487A5
JP2011504487A5 JP2010534565A JP2010534565A JP2011504487A5 JP 2011504487 A5 JP2011504487 A5 JP 2011504487A5 JP 2010534565 A JP2010534565 A JP 2010534565A JP 2010534565 A JP2010534565 A JP 2010534565A JP 2011504487 A5 JP2011504487 A5 JP 2011504487A5
Authority
JP
Japan
Prior art keywords
glucan
composition according
composition
item
carrier protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010534565A
Other languages
English (en)
Japanese (ja)
Other versions
JP5588874B2 (ja
JP2011504487A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/003582 external-priority patent/WO2009077854A2/en
Publication of JP2011504487A publication Critical patent/JP2011504487A/ja
Publication of JP2011504487A5 publication Critical patent/JP2011504487A5/ja
Application granted granted Critical
Publication of JP5588874B2 publication Critical patent/JP5588874B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010534565A 2007-11-26 2008-11-26 アジュバント添加されたグルカン Expired - Fee Related JP5588874B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US439607P 2007-11-26 2007-11-26
US61/004,396 2007-11-26
US13373808P 2008-07-01 2008-07-01
US61/133,738 2008-07-01
PCT/IB2008/003582 WO2009077854A2 (en) 2007-11-26 2008-11-26 Adjuvanted glucans

Publications (3)

Publication Number Publication Date
JP2011504487A JP2011504487A (ja) 2011-02-10
JP2011504487A5 true JP2011504487A5 (enExample) 2013-01-10
JP5588874B2 JP5588874B2 (ja) 2014-09-10

Family

ID=40795943

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010534565A Expired - Fee Related JP5588874B2 (ja) 2007-11-26 2008-11-26 アジュバント添加されたグルカン

Country Status (8)

Country Link
US (1) US20100266626A1 (enExample)
EP (1) EP2227248B2 (enExample)
JP (1) JP5588874B2 (enExample)
CA (1) CA2706617A1 (enExample)
ES (1) ES2495744T5 (enExample)
PL (1) PL2227248T3 (enExample)
PT (1) PT2227248E (enExample)
WO (1) WO2009077854A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020059A2 (en) 2000-09-01 2002-03-14 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Vibrio cholerae o139 conjugate vaccines
US9439954B2 (en) * 2007-11-26 2016-09-13 Glaxosmithkline Biologicals Sa Conjugated beta-1,3-linked glucans
CN102740882A (zh) 2009-08-27 2012-10-17 诺华有限公司 含有铝、寡核苷酸和聚阳离子的佐剂
WO2011080595A2 (en) 2009-12-30 2011-07-07 Novartis Ag Polysaccharide immunogens conjugated to e. coli carrier proteins
WO2014053521A2 (en) 2012-10-02 2014-04-10 Novartis Ag Nonlinear saccharide conjugates
ES2887367T3 (es) 2013-10-09 2021-12-22 Toray Industries Inmunopotenciador
KR102111039B1 (ko) 2018-10-30 2020-05-14 아주대학교산학협력단 항원특이적 면역반응 억제를 위한 커들란의 설하 투여용 조성물
CN112076209A (zh) * 2019-06-14 2020-12-15 青岛海洋生物医药研究院股份有限公司 一种β-葡聚糖组合物及其用途
CN112451659B (zh) * 2020-11-30 2022-09-23 山东大学 一种可德兰多糖-季铵化壳聚糖结合物纳米颗粒及其制备方法和应用
EP4486387A1 (en) 2022-02-28 2025-01-08 Tridem Bioscience GmbH & Co KG A conjugate consisting of or comprising at least a ss-glucan or a mannan
AU2023225283A1 (en) 2022-02-28 2024-08-22 Tridem Bioscience Gmbh & Co Kg A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
JPH062676B2 (ja) * 1989-02-20 1994-01-12 台糖株式会社 水溶性グルカンからなる魚病の予防剤
HU212924B (en) † 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
EP0640348A1 (en) * 1993-07-26 1995-03-01 Akzo Nobel N.V. Oil-based and water-based adjuvant mixture
US20040127458A1 (en) * 2000-11-06 2004-07-01 Hunter Kenneth W. Beta-glucan containing compositions, methods for manufacturing beta-glucans, and for manufacturing and using beta-glucans and conjugates thereof as vaccine adjuvants
GB0211118D0 (en) * 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
WO2004100965A1 (ja) * 2003-05-15 2004-11-25 Japan Science And Technology Agency 免疫刺激剤
US9439954B2 (en) * 2007-11-26 2016-09-13 Glaxosmithkline Biologicals Sa Conjugated beta-1,3-linked glucans

Similar Documents

Publication Publication Date Title
JP2011504487A5 (enExample)
JP5637689B2 (ja) 修飾糖類
CA2450203A1 (en) Capsular polysaccharide solubilisation and combination vaccines
JP2011504535A5 (enExample)
JP7439174B2 (ja) 免疫原性コンジュゲート及びその使用
US20240366743A1 (en) Multivalent Pneumococcal Glycoconjugate Vaccines Containing Emerging Serotype 24F
KR20150060986A (ko) 비선형 사카라이드 컨주게이트
JP2017523985A (ja) 抗原用担体分子
JP2010539256A5 (enExample)
EP3544637B1 (en) Native omv-antigen conjugates and use thereof
JP2008518953A5 (enExample)
JP7568746B2 (ja) タンパク質／ペプチド抗原の免疫原性を向上させる方法
JP4918356B2 (ja) Ｙ群髄膜炎菌ワクチン及びそれらの髄膜炎菌組合せワクチン
WO2018067596A1 (en) Klebsiella pneumoniae capsule polysaccharide vaccines
RU2830627C1 (ru) Способ повышения иммуногенности белкового/пептидного антигена
EP3664837A1 (en) MULTI-FUNCTIONALIZED nOMV CONJUGATES
KR20220018939A (ko) 폐렴구균 다당류-세포벽 유래 물질 접합체를 포함하는 면역원성 조성물
JP2017514961A (ja) Ｏ−アセチル化高分子ポリガラクツロン酸およびＶｉ多糖類ワクチンとしてのその利用